The foundation

The Beug Foundation for Metastasis Research recognizes that the molecular bases of metastasis still remain elusive and thus represent an area of significant opportunity for progress.

The prizes awarded by the Foundation aim to support basic research on cancer metastasis mechanisms and promote both basic and translational research, the ultimate aim being the development of novel therapies. The focus of the prize (call open) is based on Hartmut Beug’s idea of supporting “new and original approaches to basic research on cancer metastasis, as well as new activities in the field of translational research”.

The founder, Dr. Hartmut Beug, recognized that many key findings in basic cancer research are not pursued because their clinical applicability is not immediately evident. This is particularly true for cancer metastasis, which is the cause of death in over 80% of cancer patients. The molecular basis of metastasis is largely unknown and, as such, represents an area of significant opportunity for progress. Relevant preliminary results are difficult to obtain when mechanisms of action are complex.

The Metastasis Prize

The focus of the prize is based on Hartmut Beug’s idea, to support  “new and original approaches to basic research on cancer metastasis, as well as new activities in the field of translational research”. Through this prize, the foundation offers a financial seed to obtain the first preliminary data that are required to convince funding institutions to further support this project.

We invite you to join us at the 2nd joint EACR-MRS Conference on Seed and Soil: Mechanisms of Metastasis. This is a joint conference organised by the European Association for Cancer Research (EACR) and Metastasis Research Society (MRS).
Metastasis formation is responsible for over 90% of cancer patient deaths, largely due to the fact that therapies are generally ineffective against detectable metastatic tumors. There is thus a crucial need to mechanistically understand the cellular, tissue and whole-body processes driving metastasis formation in order to identify effective therapeutic strategies. This conference will give an in-depth overview of our current knowledge on cancer, stromal and immune cell centered mechanisms promoting metastasis formation presented by world-leading researchers in the field.

The 2019 awardees will present their project at the EACR “Seed and Soil 2019” meeting.


Hartmut Beug was a pioneering spirit who saw early on the value of investigating the plasticity and invasiveness of cancer cells as a necessary step towards understanding metastasis. The study of metastasis is now wide open to many technologies and talents, and its pursuit stands to provide fundamental knowledge for the treatment of cancer. Funding metastasis research offers an opportunity of contribute to medical impact of historical proportions.

Joan Massagué, PhD

Chair, Cancer Biology & Genetics Program, SKI Memorial Sloan Kettering Cancer Center, New York, USA


The Beug Stiftung was created in the hope of raising awareness of the importance of cancer metastasis research and the need for additional funding. We understand that cancer touches the lives of almost everyone and realize that we are not alone in our desire to find a cure. Thanks to people like you who share our vision of a world with better treatment options for cancer patients, we promote cutting edge science to fight one of the biggest killers in modern medicine – cancer metastasis.

You can further our cause by helping us with your donation.